Novel therapies for the management of short bowel syndrome in children

Pediatric Surgery International

Volumn 29, Issue 10, 2013, Pages 967-974

  Schwartz, Marshall Z ^a,b,c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

Gene alteration; Growth factors; Intestinal adaptation; Intestinal failure; Short bowel syndrome

Indexed keywords

ANTIBIOTIC AGENT; EPIDERMAL GROWTH FACTOR; GLUCAGON LIKE PEPTIDE 2; GLUTAMINE; GROWTH FACTOR; GROWTH HORMONE; IMMUNOSUPPRESSIVE AGENT; OCTREOTIDE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; SCATTER FACTOR; SOMATOMEDIN C; SOMATOSTATIN;

ABDOMINAL PAIN; ABSORPTION; ENTERIC FEEDING; FLUSHING; HEADACHE; HUMAN; INTRAVENOUS FEEDING; JEJUNOSTOMY; LIVER RESECTION; NAUSEA; NONHUMAN; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SHORT BOWEL SYNDROME; SIDE EFFECT; SMALL INTESTINE RESECTION; TISSUE ENGINEERING;

CHILD; DISEASE MANAGEMENT; ENTERAL NUTRITION; HUMANS; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME;

EID: 84885630605     PISSN: 01790358     EISSN: 14379813     Source Type: Journal    
DOI: 10.1007/s00383-013-3404-7     Document Type: Review

References (61)

1. Budding J, Smith CC (1967) Role of recirculating loops in the management of massive resection of the small intestine. Surg Gynecol Obstet 125:243-249
2. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE (1968) Long-term total parenteral nutrition with growth, development and positive nitrogen balance. Surg 64:134-142
3. Bianchi A (1980) Intestinal loop lengthening-A technique for increasing small intestinal length. J Pediatr Surg 15:145-151 (Pubitemid 10110498)
4. Miller LR, Jacobson ED, Johnson LR (1973) Effect of pentagastrin on gastric mucosal cells grown in tissue culture. Gastroenterology 64:254
5. Johnson LR (1976) The trophic action of gastrointestinal hormones. Gastroenterology 70:278-288
6. Schwartz MZ, Storozuk RB (1985) Enhancement of small intestine function by gastrin. J Surg Res 38:613-617 (Pubitemid 16211177)
7. Schwartz MZ, Storozuk RB (1985) Can gastrointestinal hormones enhance intestinal absorption? Surgery 98:430-436 (Pubitemid 16143768)
8. Schwartz MZ, Storozuk RB (1988) Influence of epidermal growth factor on intestinal function in the rat: comparison of systemic infusion versus luminal perfusion. Am J Surg 155:18-22 (Pubitemid 18063519)
9. Schwartz MZ, Flye MW, Storozuk RB (1985) Growth and function of transplanted fetal rat intestine: effect of cyclosporine. Surgery 97:481-486 (Pubitemid 15074403)
10. Schwartz MZ, Storozuk RB (1988) Influence of epidermal growth factor on intestinal function in the rat: comparison of systemic infusion versus luminal perfusion. Am J Surg 155:18-22 (Pubitemid 18063519)
11. Lukish J, Yu D, Kato Y, Schwartz MZ (1996) The effect of certain growth factors on intestinal function and adaptation following massive small bowel resection. Gastroenterology 110:A818
12. Green DW, Gomez G, Greeley G Jr (1989) Gastrointestinal peptides. Gastroenterol Clin North Am 18:695-733 (Pubitemid 20077326)
13. Devorkin KD, Levine GM, Farber NJ et al (1976) Small intestine mass of the rat is partially determined by indirect effects of luminal nutrition. Gastroenterology 71:626
14. Harris AG (1994) Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut 35:S1-S4 suppl
15. Dharmsathaphorn K, Gorelick FS, Sherwin RS et al (1982) Somatostatin decreases diarrhea in patients with short bowel syndrome. J Clin Gastroenterol I4:521-552
16. O'Keefe SID, Peterson ME, Fleming CR (1994) Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. J Parenter Enter Nutr 18:26-36 (Pubitemid 24020755)
17. Nightingale JM, Walker ER, Burnham WR et al (1990) Short bowel syndrome. Digestion 45:77-83 suppl (Pubitemid 20088682)
18. Ohlbaum PH, Galperine RI, Demarquez JL et al (1987) Use of a long acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child. J Pediatr Gastroenterol Nutr 6:466-470 (Pubitemid 17073445)
19. O'Keefe SJ, Haymond MW, Bennet WM et al (1994) Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 107:379-388 (Pubitemid 24233311)
20. Seydel AS, Miller JH, Sarac HC et al (1996) Octreotide diminishes luminal nutrient transport activity, which is reversed by epidermal growth factor. Am J Surg 172:267-271 (Pubitemid 26327913)
21. Vanderhoof JA, Kollman KA (1998) Lack of inhibitory effect of octreotide on intestinal adaptation in short bowel syndrome in the rat. J Pediatr Gastroenterol Nutr 26:241-244 (Pubitemid 28120023)
22. Ladefoged K, Christensen KC, Hegnhoj J et al (1989) Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut 30:943-949 (Pubitemid 19187935)
23. Tamada H, Nezu R, Imamura I et al (1992) The dipeptide alanyl-glutamine prevents intestinal mucosal atrophy in parenterally fed rats. J Parenter Enteral Nutr 16:110-116
24. Tamada H, Nezu R, Matsuo Y et al (1993) Alanyl glutamine-enriched total parenteral nutrition restores intestinal adaptation after either proximal or distal massive resection in rats. J Parenter Enteral Nutr 17:236-242 (Pubitemid 23136129)
25. Wilmore DW (1997) Metabolic support of the gastrointestinal tract. Cancer 79:1794-1803
26. Guarino A, Canani RB, Lafusco M et al (1995) In vivo and in vitro effects of human growth hormone on rat intestine ion transport. Pediatr Res 37:576-580
27. Benhamou PH, Canarelli JP, Richard S et al (1997) Human recombinant growth hormone increases small bowel lengthening after massive small bowel resection in piglets. J Pediatr Surg 32:1332-1336 (Pubitemid 27391562)
28. Inoue Y, Copeland EM, Souba WW (1994) Growth hormone enhance amino acid uptake by the human small intestine. Ann Surg 219:715-724 (Pubitemid 24182647)
29. Byrne TA, Persinger RL, Young LS et al (1995) A new treatment for patients with short-bowel syndrome. Ann Surg 222:243-255
30. Wilmore DW (1999) Growth factors and nutrients in the short bowel syndrome. JPEN 23:S117-S120 suppl
31. Wilmore DW, Lacey JM, Soultanakis RP et al (1997) Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 226:288-293 (Pubitemid 28070921)
32. Scolapio JS, Fleming CR, Camilleri MC et al (1997) Effect of growth hormone, glutamine and diet on adaptation in the short bowel syndrome: a randomized controlled study. Gastroenterology 113:1074-1081 (Pubitemid 27418959)
33. Lukish JR, Yu D, Kato Y et al (1996) Persistent upregulation in intestinal function beyond intestinal adaptation following luminal growth factor perfusion. Surg Forum 47:675-678
34. Chaet MS, Ziegler MM, Warner BW (1994) Epidermal growth factor enhances intestinal adaptation after massive small bowel resection. J Pediatr Surg 29:1035-1039 (Pubitemid 24265642)
35. Thompson IS (1999) Epidermal growth factor and the short bowel syndrome. J Parenter Enteral Nutr 23:S113-S116
36. Chen K, Okuma T, Okamura K et al (1995) Insulin like growth factor-I prevents gut atrophy and maintains intestinal integrity in septic rats. J Parenter Enteral Nutr 19:119-124
37. Lemmey AB, Ballard FJ, Martin AA et al (1994) Treatment with IGF-l peptides improves function of the remaining gut following small bowel resection in rats. Growth Factors 10:243-252 (Pubitemid 24254248)
38. Gleeson MR, Bloom SR, Polak IM et al (1971) Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut 12:773-782
39. Stevens FM, Flanagan RW, O'Gorman D et al (1984) Glucagonoma syndrome demonstrating giant duodenal villi. Gut 25:784-791 (Pubitemid 14086209)
40. Drucker DJ, Ehrlich P, Asa SL et al (1996) Induction of intestinal epithelial proliferation by glucagon-like peptide-2. Proc Natl Acad Sci USA 93:7911-7916 (Pubitemid 26277138)
41. Fischer KD, Dhanvantari S, Drucker DJ et al (1997) Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats. Am J Physiol 273:E815-E820
42. Drucker DL, Deforest L, Brubaker PL (1997) Intestinal response to growth factors administered alone or in combination with human [Gly2] glucagon-like peptide 2. Am J Physiol 273:G1252-G1262
43. Kato Y, Alavi K, Yu D et al (1998) Glucagon-like peptide-2 enhances intestinal function following massive small bowel resection. Gastroenterology 114:A1l52
44. Kato Y, Yu D, Schwartz MZ (1999) Glucagon-like peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo. J Pediatr Surg 34:18-20 (Pubitemid 29047245)
45. Prasad R, Alavi K, Schwartz MZ (1999) Glucagon-like peptide-2 analogue enhances intestinal mucosal mass and absorptive function after ischemia-reperfusion injury. Surg Forum 50:563-564
46. Jasleen J, Shimoda N, Shen ER et al (2000) Signaling mechanisms of glucagon-like peptide-2-induced intestinal epithelial cell proliferation. J Surg Res 90:13-18 (Pubitemid 30317171)
47. O'Keefe S, Gilroy R, Jeppesen PB et al (2008) Teduglutide, a novel GLP-2 analog in the management of short bowel syndrome patients dependent on parenteral nutrition: a multicenter, multinational placebo-controlled clinical trial. Gastroenterology 134:A37
48. Jeppesen PB, Hartmann B, Hansen BS et al (1999) Impaired meal stimulated glucagon-like peptide-2 response in ileal resected short bowel patients with intestinal failure. Gut 45:559-563 (Pubitemid 29447825)
49. Wolf HK, Zarneger R, Michalopoulos GK (1991) Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology 14:488-494
50. Bottaro DP, Rubin JS, Faletto DL et al (1991) Identification of the hepatocyte growth factor receptor as the c-Met proto-oncogene product. Science 251:802-804 (Pubitemid 21926175)
51. Naldini L, Vigna E, Narsimhan R et al (1991) Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-met. Oncogene 6:501-504 (Pubitemid 21924112)
52. Fukamachi H, Tsukada S, Ichinose M et al (1994) Hepatocyte growth factor region specifically stimulates gastro-intestinal epithelial growth in primary culture. Biochem Biophys Res Commun 205:1445-1451
53. Nishimura S, Takahashi M, Ota S et al (1998) Hepatocyte growth factor accelerates restitution of intestinal epithelial cells. J Gastroenterol 33:172-178 (Pubitemid 28143393)
54. Okamura M, Kurauchi O, Itakura A et al (1998) Hepatocyte growth factor in human amniotic fluid promotes the migration of fetal small intestinal epithelial cells. Am J Obst Gyn 178:175-179 (Pubitemid 28302816)
55. Kato Y, Yu D, Lukish JR et al (1997) Hepatocyte growth factor enhances intestinal mucosal cell function and mass in vivo. J Pediatr Surg 32:991-994 (Pubitemid 27349010)
56. Kato Y, Yu D, Lukish JR et al (1997) Influence of hepatocyte growth factor on small intestine mucosa in vivo. J Surg Res 71:49-53 (Pubitemid 27344035)
57. Kato Y, Yu D, Schwartz MZ (1998) Enhancement of intestinal adaptation by hepatocyte growth factor. J Pediatr Surg 33:235-239 (Pubitemid 28093705)
58. Sunitha I, Shen R, McKillop IH et al (1999) A src-related kinase in the brush border membranes of gastrointestinal cells in regulated by c-met. Exper Cell Res 250:86-98 (Pubitemid 29391573)
59. Kato Y, Yu D, Schwartz MZ (1998) Hepatocyte growth factor upregulates SGLTl and GLUT5 gene expression after massive small bowel resection. J Pediatr Surg 33:13-15 (Pubitemid 28060371)
60. Barthel ER, Speer AL, Levin DE et al (2012) Tissue engineering of the intestine in a murine model. J Vis Exp 70:e4279
61. Katz MS, Thatch KA, Schwartz MZ (2011) The effect of hepatocyte growth factor (HGF) on gene transcription during intestinal adaptation. J Pediatr Surg 46(2):357-365